Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019

2019-12-01
Price :
Published : Dec-2019
No. of Pages : 473
Table of Contents
1.1 List of Tables 10
1.2 List of Figures 18
2 Introduction 19
2.1 Immunochemistry Analyzers Overview 19
3 Products under Development 20
3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development 20
3.2 Immunochemistry Analyzers - Pipeline Products by Segment 21
3.3 Immunochemistry Analyzers - Pipeline Products by Territory 22
3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path 23
3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 24
3.6 Immunochemistry Analyzers - Ongoing Clinical Trials 25
4 Immunochemistry Analyzers - Pipeline Products under Development by Companies 26
4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 26
4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development 31
5 Immunochemistry Analyzers Companies and Product Overview 35
6 Immunochemistry Analyzers- Recent Developments 181
6.1 Nov 12, 2019: New breakthrough in Lyme Disease testing reduces time to results from days to minutes 181
6.2 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 181
6.3 Nov 06, 2019: Meridian submits Curian analyzer and the Curian HpSA assay to the FDA 184
6.4 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results 184
6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 185
6.6 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 187
6.7 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 188
6.8 Oct 31, 2019: BioTek launches a set of quantitative assay apps to simplify detection-based applications 190
6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 190
6.10 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 191
6.11 Oct 31, 2019: SDI Group: Change of name 192
6.12 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance 192
6.13 Oct 30, 2019: Quidel reports third quarter 2019 financial results 193
6.14 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 194
6.15 Oct 30, 2019: Tecan appoints Ralf Griebel a member of the Management Board and Head of Partnering Business 196
6.16 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 196
7 Appendix 468
7.1 Methodology 468
7.2 About GlobalData 471
7.3 Contact Us 471
7.4 Disclaimer 471

List of Tables
Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 26
Table 2: Immunochemistry Analyzers - Pipeline Products by Segment 27
Table 3: Immunochemistry Analyzers - Pipeline Products by Territory 28
Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 29
Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 30
Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials 31
Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 32
Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development 37
Table 9: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 10: All-in-One Sensor - Product Status 41
Table 11: All-in-One Sensor - Product Description 41
Table 12: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43
Table 13: BioLED Device - Diabetes Management - Product Status 43
Table 14: BioLED Device - Diabetes Management - Product Description 43
Table 15: ADOR Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
Table 16: NATlab - Product Status 44
Table 17: NATlab - Product Description 44
Table 18: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 45
Table 19: AgPlus Diagnostic System - Product Status 45
Table 20: AgPlus Diagnostic System - Product Description 45
Table 21: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 22: minDNAnalyzer - Product Status 46
Table 23: minDNAnalyzer - Product Description 47
Table 24: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 25: TruDx 2000 Platform - Product Status 48
Table 26: TruDx 2000 Platform - Product Description 48
Table 27: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 28: Clondiag HIV Molecular Device - Product Status 49
Table 29: Clondiag HIV Molecular Device - Product Description 49
Table 30: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 31: BiliNow - Product Status 50
Table 32: BiliNow - Product Description 50
Table 33: PKU Now - Product Status 51
Table 34: PKU Now - Product Description 51
Table 35: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 36: ApoStream System - Product Status 52
Table 37: ApoStream System - Product Description 52
Table 38: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 39: Point Of Care Diagnostic Device - Phenylketonuria - Product Status 53
Table 40: Point Of Care Diagnostic Device - Phenylketonuria - Product Description 53
Table 41: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 54
Table 42: Atolyzer Consumer Device - Product Status 54
Table 43: Atolyzer Consumer Device - Product Description 54
Table 44: Atolyzer Gene - Product Status 55
Table 45: Atolyzer Gene - Product Description 55
Table 46: Atolyzer PoC - Product Status 55
Table 47: Atolyzer PoC - Product Description 56
Table 48: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 49: markB - Product Status 57
Table 50: markB - Product Description 57
Table 51: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 52: UniCel DxN - Product Status 59
Table 53: UniCel DxN - Product Description 59
Table 54: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview 60
Table 55: U-PAC - Product Status 60
Table 56: U-PAC - Product Description 60
Table 57: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 58: Magnetic Immunoassay Detection System - Product Status 62
Table 59: Magnetic Immunoassay Detection System - Product Description 62
Table 60: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 61: TR-LFIA Diagnostic Analyzer - Product Status 64
Table 62: TR-LFIA Diagnostic Analyzer - Product Description 64
Table 63: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
Table 64: MONITOR System - Product Status 65

List of Figures
Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 22
Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment 23
Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory 24
Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 25
Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 26
Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials 27
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData